Does PEGINTERFERON ALFA-2B Cause Neoplasm malignant? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Neoplasm malignant have been filed in association with PEGINTERFERON ALFA-2B. This represents 0.3% of all adverse event reports for PEGINTERFERON ALFA-2B.
11
Reports of Neoplasm malignant with PEGINTERFERON ALFA-2B
0.3%
of all PEGINTERFERON ALFA-2B reports
2
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm malignant From PEGINTERFERON ALFA-2B?
Of the 11 reports, 2 (18.2%) resulted in death.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGINTERFERON ALFA-2B. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does PEGINTERFERON ALFA-2B Cause?
Anaemia (804)
Platelet count decreased (593)
Pyrexia (440)
White blood cell count decreased (420)
Haemoglobin decreased (281)
Neutrophil count decreased (272)
Nausea (269)
Rash (269)
Fatigue (245)
Decreased appetite (224)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which PEGINTERFERON ALFA-2B Alternatives Have Lower Neoplasm malignant Risk?
PEGINTERFERON ALFA-2B vs PEGINTERFERON BETA-1A
PEGINTERFERON ALFA-2B vs PEGINTRON
PEGINTERFERON ALFA-2B vs PEGLOTICASE
PEGINTERFERON ALFA-2B vs PEGUNIGALSIDASE ALFA-IWXJ
PEGINTERFERON ALFA-2B vs PEGVALIASE-PQPZ